PMID- 24939607 OWN - NLM STAT- MEDLINE DCOM- 20150407 LR - 20211021 IS - 1868-601X (Electronic) IS - 1868-4483 (Linking) VI - 5 IP - 5 DP - 2014 Oct TI - Gellan sulfate core platinum coil with tenascin-C promotes intra-aneurysmal organization in rats. PG - 595-603 LID - 10.1007/s12975-014-0352-z [doi] AB - The aims of this study were to develop a new coil, gellan sulfate core platinum coil (GSCC), that delivers tenascin-C (TNC) to an aneurysm (GSCC-TNC) and to evaluate the effects on intra-aneurysmal organization. We performed in vitro adsorption tests of TNC to gellan sulfate (GS). GSCC-TNC was produced by immersing GSCC in TNC solution under the following conditions (TNC concentration 10, 50, or 100 mug/mL; TNC immersion time 15, 30, or 60 min) by monitoring intra-aneurysmal organization in a rat blind-ended aneurysm model. In addition, 20 rats randomly underwent implantation of a platinum coil or the GSCC-TNC produced under optimum conditions into an aneurysm, whose organization effects were compared in a blind fashion at 2 weeks post-surgery. GS demonstrated a high affinity to TNC in a dose-dependent fashion (affinity constant = 1.79 x 10(10) (M(-1))). GSCC immersed in 10 mug/mL of TNC solution for 30 and 60 min induced similar and better organization of aneurysmal cavity compared with that for 15 min (the ratio of the organized areas in an aneurysmal cavity-15 min, 27.2 +/- 11.8 %; 30 min, 75.6 +/- 11.9 %; 60 min, 82.6 +/- 19.7 %, respectively) with the preservation of the aneurysmal wall structure, while higher TNC concentrations caused the destruction of the aneurysmal wall. GSCC-TNC produced under 10 mug/mL of TNC solution for 30 min showed a significantly better organization of aneurysms compared with bare platinum coils in rats. A newly developed coil, GSCC-TNC, may be effective for improving intra-aneurysmal organization after coil embolization. FAU - Hamada, Kazuhide AU - Hamada K AD - Department of Neurosurgery, Mie University Graduate School of Medicine, 2-174 Edobashi, Tsu, Mie, 514-8507, Japan. FAU - Miura, Yoichi AU - Miura Y FAU - Toma, Naoki AU - Toma N FAU - Miyamoto, Keiichi AU - Miyamoto K FAU - Imanaka-Yoshida, Kyoko AU - Imanaka-Yoshida K FAU - Matsushima, Satoshi AU - Matsushima S FAU - Yoshida, Toshimichi AU - Yoshida T FAU - Taki, Waro AU - Taki W FAU - Suzuki, Hidenori AU - Suzuki H LA - eng PT - Journal Article PT - Research Support, Non-U.S. Gov't DEP - 20140619 PL - United States TA - Transl Stroke Res JT - Translational stroke research JID - 101517297 RN - 0 (Polysaccharides) RN - 0 (Sulfuric Acid Esters) RN - 0 (Tenascin) RN - 0 (gellan sulfate) RN - 49DFR088MY (Platinum) SB - IM MH - Animals MH - Disease Models, Animal MH - Embolization, Therapeutic/*instrumentation MH - Intracranial Aneurysm/pathology/*therapy MH - Male MH - Platinum MH - Polysaccharides MH - Rats MH - Rats, Sprague-Dawley MH - Sulfuric Acid Esters MH - Tenascin/*administration & dosage/pharmacokinetics EDAT- 2014/06/19 06:00 MHDA- 2015/04/08 06:00 CRDT- 2014/06/19 06:00 PHST- 2014/03/26 00:00 [received] PHST- 2014/06/04 00:00 [accepted] PHST- 2014/05/11 00:00 [revised] PHST- 2014/06/19 06:00 [entrez] PHST- 2014/06/19 06:00 [pubmed] PHST- 2015/04/08 06:00 [medline] AID - 10.1007/s12975-014-0352-z [doi] PST - ppublish SO - Transl Stroke Res. 2014 Oct;5(5):595-603. doi: 10.1007/s12975-014-0352-z. Epub 2014 Jun 19.